Mixed treatment comparison of infliximab with ustekinumab in patients with moderate to severe psoriasis

被引：0
|
作者：
Fan, T. [1 ]
Bennett, H. [2 ]
Smith, N. [2 ]
Marin, M. [2 ]
Shuvayu, S. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] OptumInsight, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E38 / E39
页数：2
相关论文
共 50 条
  • [21] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Croxtall, Jamie D.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (02) : 135 - 137
  • [22] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Aguirre, A.
    Guerrero, E.
    Hernandez, N.
    Coronell, S.
    Argote, A. C.
    Giraldo, C., V
    Ojeda, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A211 - A211
  • [23] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Jamie D. Croxtall
    [J]. American Journal of Clinical Dermatology, 2012, 13 : 135 - 137
  • [24] Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
    Chan, Wai Sze Agnes
    Wong, Yisheng
    Oon, Hazel Hwee Boon
    Theng, Colin Thiam Seng
    Chong, Wei-Sheng
    [J]. SINGAPORE MEDICAL JOURNAL, 2023, 64 (07) : 434 - 438
  • [25] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Ojeda, C.
    Hernandez, N.
    Giraldo, C., V
    Argote, A. C.
    Coronell, S.
    Roa, M.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A124 - A124
  • [26] Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis
    Scanlon, James V.
    Exter, Benjamin P.
    Steinberg, Michael
    Jarvis, Courtney I.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (09) : 1456 - 1465
  • [27] COST EFFICACY OF USTEKINUMAB IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN TURKEY
    Tatar, M.
    Sarioz, F.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A146 - A147
  • [28] Infliximab clears psoriasis in 80% of patients with moderate to severe disease
    Chaudhari, U
    Romano, P
    Mulcahy, L
    Dooley, L
    Baker, D
    Gottlieb, A
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 545 - 545
  • [29] Nail psoriasis improvement is maintained in patients with moderate to severe psoriasis treated with infliximab
    Rich, P.
    Guzzo, C.
    Li, S.
    Reich, K.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB178 - AB178
  • [30] COST PER RESPONDER OF APREMILAST VERSUS INFLIXIMAB BIOSIMILAR, ETANERCEPT, ADALIMUMAB, USTEKINUMAB AND SECUKINUMAB IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN SPAIN
    Martinez-Sesmero, J. M.
    Schoendorff, C.
    Caloto, T.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A569 - A569
12345